The clinical characteristics of coronavirus disease 2019 in mild and ordinary female patients
- Authors: Jiang Y.1,2, Li Y.2,3, Yuan D.2,4, Hou G.5
-
Affiliations:
- Zhejiang Chinese Medical University
- Cancer Hospital of the University of Chinese Academy of Sciences
- Institute of Cancer and Basic Medicine
- Bengbu Medical College
- Huangpi People's Hospital of Jianghan University
- Issue: Vol 25, No 2 (2020)
- Pages: 56-64
- Section: ORIGINAL STUDIES
- URL: https://journals.rcsi.science/1560-9529/article/view/43887
- DOI: https://doi.org/10.17816/EID43887
- ID: 43887
Cite item
Abstract
AIMS: the aim of study was to explore the clinical characteristics of coronavirus disease 2019 in mild and ordinary patients, providing guidance for clinical diagnosis and treatment.
MATERIALS AND METHODS: Sixty-four patients with positive results of nucleic acid testing were divided into two groups, called the youth group and the older group, to be compared the differences of clinical characteristics.
RESULTS: Sixty-nine cases showed normal or decrease in white blood cell count (WBC). One case decreased in lymphocyte count (LYMPH). Seven cases decreased in lymphocyte proportion (LYMPH%). Seven cases increased in C-reactive protein (CRP). Sixteen cases increased in alanine transaminase (ALT). Nineteen cases increased in aspartate transaminase (AST). One case increased in lactic dehydrogenase (LDH). Six cases decreased in creatine kinase (CK). Three cases increased in globulin (GLOB). Thirty-eight cases decreased in serum creatinine (CRE). Five cases decreased in blood urea nitrogen (BUN). The lung CT scanning results showed no statistic difference between two groups (p > 0.05). The level of WBC, NEUT, LDH, BUN, potassium (K+) showed statistic difference between two groups (p ˂ 0.05).
CONCLUSIONS: Age was a risk factor in COVID-19. In the course of future diagnosis and treatment, blood test might play an increasingly important role.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Yaona Jiang
Zhejiang Chinese Medical University; Cancer Hospital of the University of Chinese Academy of Sciences
Email: jiangyaona@126.com
ORCID iD: 0000-0001-5431-4126
China
Yaqing Li
Cancer Hospital of the University of Chinese Academy of Sciences; Institute of Cancer and Basic Medicine
Author for correspondence.
Email: lidoctor03@126.com
ORCID iD: 0000-0002-7379-8151
China
Dong Yuan
Cancer Hospital of the University of Chinese Academy of Sciences; Bengbu Medical College
Email: 1002376662jrs@gmail.con
ORCID iD: 0000-0002-8723-5077
China
Guanghua Hou
Huangpi People's Hospital of Jianghan University
Email: houguanghua11@126.com
China